How much does Emblaveo (Aztreonam and Avibactam Sodium for Injection) Cost& price without insurance in China?
Emblaveo® is the commercial brand name of Aztreonam and Avibactam Sodium for Injection, a combination antibacterial drug developed by Pfizer. It consists of aztreonam (a monobactam antibiotic) and avibactam (a β-lactamase inhibitor), used to treat infections caused by Gram-negative bacteria producing β-lactamases.
Main Indications
Treatment of complicated intra-abdominal infections (cIAI), complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible Gram-negative pathogens in adults.
Common Side Effects
Common mild adverse reactions: Diarrhea, nausea, vomiting, headache, and infusion site reactions.
Laboratory abnormalities: Elevated liver enzymes, decreased white blood cell count, and prolonged prothrombin time.
Severe but uncommon risks: Severe hypersensitivity reactions, Clostridioides difficile-associated diarrhea, and renal function impairment.
Approval Status in China
Emblaveo® (Aztreonam and Avibactam Sodium for Injection, 2.0g per vial) was officially approved for marketing in China in 2024. It is currently a prescription antibacterial drug.
Buy Emblaveo (Aztreonam and Avibactam Sodium for Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
